Immunogenicity and protective efficacy of recombinant iron superoxide dismutase protein fromBordetella pertussisin mice models

The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A

(2015) Valentina Agnolon et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Pertussis Vaccines: State-of-the-Art and Future Trends

(2013) Burcu Tefon et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Bordetella pertussis iron regulated proteins as potential vaccine components

(2013) Jimena Alvarez Hayes et al.   VACCINE

Resurgence of pertussis calls for re-evaluation of pertussis animal models

(2012) Arno AJ van der Ark et al.   Expert Review of Vaccines

Identification of a new protective antigen of Bordetella pertussis

(2011) Jimena Alvarez Hayes et al.   VACCINE

A comprehensive analysis of Bordetella pertussis surface proteome and identification of new immunogenic proteins

(2011) Burcu E. Tefon et al.   VACCINE

Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant

(2008) C. R. Casella et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Factors contributing to pertussis resurgence

(2008) Qiushui He et al.   Future Microbiology

Pertussis: review of epidemiology, diagnosis, management and prevention

(2008) Nicholas Wood et al.   Paediatric Respiratory Reviews

Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model

(2008) Nico Marr et al.   VACCINE

Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins

(2008) Emrah Altındiş et al.   VACCINE